Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
Cardiac glycoside that inhibits Na+/K+ ATPase activity which can indirectly affect the function of Ena1. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Another cardiac glycoside that inhibits Na+/K+ ATPase which can indirectly interfere with Ena1. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Inhibitor of sodium channels, altering sodium homeostasis, thus potentially affecting Ena1's function. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $54.00 | ||
Diuretic that acts on sodium channels, potentially affecting sodium homeostasis which is regulated by Ena1. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Aldosterone antagonist that can affect sodium homeostasis, thereby potentially influencing Ena1 activity. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $110.00 $624.00 | 4 | |
Selective aldosterone antagonist; by modulating sodium homeostasis, it can influence Ena1. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker; by altering ionic balance, it can indirectly affect Ena1. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
Modifies thiol groups; can affect ATPases and thus may inhibit Ena1. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Sodium ionophore affecting sodium gradients, potentially impacting Ena1. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
V-ATPase inhibitor, which by altering ionic homeostasis can indirectly affect Ena1. | ||||||